Claudin-2: A marker for a better evaluation of histological mucosal healing in inflammatory bowel diseases
Digestive and Liver Disease · 2025
DOI: 10.1016/j.dld.2024.08.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Vincenzo Villanacci und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, ASST Spedali Civili and University of Brescia, Brescia, Italy. Hauptthemen laut MEDLINE: Intestinal Mucosa, Inflammatory Bowel Diseases, Claudin-2, Wound Healing. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Histological mucosal healing has become a paramount target goal to achieve in the treatment of inflammatory bowel diseases. However, there is still a lack of agreement on the best way to reach this goal, since numerous histological scores are available worldwide. AIMS: We investigated whether claudin-2, a member of claudin family involved in the regulation of intestinal tight junctions, might be useful to assess the presence of active disease in patients with inflammatory bowel diseases. METHODS: Biopsies from 123 patients with ulcerative colitis, Crohn's disease, infectious colitides and irritable bowel syndrome patients where tested with immunohistochemistry for claudin-2. RESULTS: Claudin-2 appeared to be a very sensitive marker of disease activity in inflammatory bowel diseases, but was negative in the other kinds of patients. In addition, immunohistochemistry for claudin-2 showed good reproducibility by different pathologists. CONCLUSIONS: Should these findings be confirmed in more numerous cohorts of patients, and especially in those with minimal or focal residual disease activity, this simple assessment could be useful in the routine daily practice to facilitate the task of pathologists and clinicians in the diagnosis and management of patients with inflammatory bowel diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pathology, ASST Spedali Civili and University of Brescia, Brescia, Italy.
- Department of Medicine and Surgery, Section of Anatomic Pathology and Histology, University of Perugia, Perugia, Italy. Electronic address: rachele.delsordo@unipg.it.
- Gastroenterology Unit, Department of Clinical and Experimental Sciences, Spedali Civili Hospital, University of Brescia, Brescia, Italy.
- Department of Medicine and Surgery, Section of Anatomic Pathology and Histology, University of Perugia, Perugia, Italy.
- Gastroenterology and Hepatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Zitieren
APA
Villanacci, V., Del Sordo, R., Lanzarotto, F., Ricci, C., Sidoni, A., Manenti, S., Mino, S., Bugatti, M., & Bassotti, G. (2025). Claudin-2: A marker for a better evaluation of histological mucosal healing in inflammatory bowel diseases. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.08.001
Vancouver
Villanacci V, Del Sordo R, Lanzarotto F, Ricci C, Sidoni A, Manenti S, et al. Claudin-2: A marker for a better evaluation of histological mucosal healing in inflammatory bowel diseases. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2024.08.001
BibTeX
@article{Villanacci2025,
author = {Villanacci, Vincenzo and Del Sordo, Rachele and Lanzarotto, Francesco and Ricci, Chiara and Sidoni, Angelo and Manenti, Stefania and Mino, Sara and Bugatti, Mattia and Bassotti, Gabrio},
title = {Claudin-2: A marker for a better evaluation of histological mucosal healing in inflammatory bowel diseases},
journal = {Digestive and Liver Disease},
year = {2025},
doi = {10.1016/j.dld.2024.08.001}
}
EUVIMED